COMPILEDopen profilenot managed by this scholar
Đ
Đình Thy Hảo Vương
Researcher Profile 6/10Link copied
Information
- 🏛️Affiliation: Cho Ray Hospital
- 🔬Field: Medicine and Pharmacy
- 🆔ORCID: 0000-0001-8313-5688
- ✍️Profile incomplete — add information
Featured publications
The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases3 citations
Asia-Pacific Journal of Clinical Oncology · 2024 · DOI
Asia-Pacific Journal of Clinical Oncology · 2024 · DOI
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam3 citations
Therapeutic Advances in Medical Oncology · 2024 · DOI
Therapeutic Advances in Medical Oncology · 2024 · DOI
A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam3 citations
BMC Cancer · 2024 · DOI
BMC Cancer · 2024 · DOI
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam1 citations
Therapeutic Advances in Medical Oncology · 2025 · DOI
Therapeutic Advances in Medical Oncology · 2025 · DOI
A Real-World Cohort Study of First-Line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer in Vietnam1 citations
Research Square · 2023 · DOI
Research Square · 2023 · DOI
Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI
· 2025 · DOI
Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI
· 2025 · DOI
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam
Therapeutic Advances in Respiratory Disease · 2025 · DOI
Therapeutic Advances in Respiratory Disease · 2025 · DOI
KẾT QUẢ ĐIỀU TRỊ AFATINIB LIỀU LINH HOẠT Ở BỆNH NHÂN CAO TUỔI UTPKTBN CÓ ĐỘT BIẾN EGFR
Tạp chí Y học Việt Nam · 2024 · DOI
Tạp chí Y học Việt Nam · 2024 · DOI
About the field of Medicine and Pharmacy
Common research topics in this field:
Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions
Institutions with the most researchers in this field:
Hanoi Medical University · 422
University of Medicine and Pharmacy at Ho Chi Minh City · 418
Vietnam National University Ho Chi Minh City · 393
Can Tho University · 311
Hue University · 240
These figures count profiles currently in this directory, not nationwide statistics.
Same institution — Cho Ray Hospital
Same field Medicine and Pharmacy
The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗
Suggest / Claim this profile
Đình Thy Hảo VươngCho Ray Hospital
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.